Kristina Ruuth

1.0k total citations
23 papers, 694 citations indexed

About

Kristina Ruuth is a scholar working on Molecular Biology, Neurology and Oncology. According to data from OpenAlex, Kristina Ruuth has authored 23 papers receiving a total of 694 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 11 papers in Neurology and 9 papers in Oncology. Recurrent topics in Kristina Ruuth's work include Neuroblastoma Research and Treatments (11 papers), Cancer therapeutics and mechanisms (9 papers) and Cancer, Hypoxia, and Metabolism (6 papers). Kristina Ruuth is often cited by papers focused on Neuroblastoma Research and Treatments (11 papers), Cancer therapeutics and mechanisms (9 papers) and Cancer, Hypoxia, and Metabolism (6 papers). Kristina Ruuth collaborates with scholars based in Sweden, United States and China. Kristina Ruuth's co-authors include Bengt Hallberg, Ruth H. Palmer, Erik Lundgren, Christina Schönherr, Peter Sundström, Maria Nyström, Tommy Martinsson, Sattu Kamaraj, Therése Eriksson and Yasuo Yamazaki and has published in prestigious journals such as Cancer Research, Oncogene and Biochemical Journal.

In The Last Decade

Kristina Ruuth

23 papers receiving 676 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kristina Ruuth Sweden 13 392 387 223 170 107 23 694
Rama Jasty United States 11 372 0.9× 105 0.3× 141 0.6× 82 0.5× 142 1.3× 18 583
David Eaves United States 8 191 0.5× 307 0.8× 94 0.4× 35 0.2× 30 0.3× 9 539
John M. Krill-Burger United States 11 504 1.3× 70 0.2× 88 0.4× 118 0.7× 47 0.4× 14 679
Jacqueline A. Brosnan‐Cashman United States 13 277 0.7× 114 0.3× 368 1.7× 198 1.2× 19 0.2× 29 667
Teresa Corral Spain 8 237 0.6× 81 0.2× 164 0.7× 34 0.2× 25 0.2× 15 434
Curt J. Essenburg United States 9 180 0.5× 61 0.2× 149 0.7× 76 0.4× 34 0.3× 17 413
Torill Høiby United States 6 318 0.8× 32 0.1× 255 1.1× 100 0.6× 269 2.5× 8 658
Octavio A. Romero Spain 12 575 1.5× 33 0.1× 208 0.9× 125 0.7× 100 0.9× 15 721
T Sugimura Japan 6 404 1.0× 36 0.1× 195 0.9× 75 0.4× 29 0.3× 8 613
Neetha Parameswaran United States 14 276 0.7× 40 0.1× 225 1.0× 93 0.5× 189 1.8× 23 562

Countries citing papers authored by Kristina Ruuth

Since Specialization
Citations

This map shows the geographic impact of Kristina Ruuth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kristina Ruuth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kristina Ruuth more than expected).

Fields of papers citing papers by Kristina Ruuth

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kristina Ruuth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kristina Ruuth. The network helps show where Kristina Ruuth may publish in the future.

Co-authorship network of co-authors of Kristina Ruuth

This figure shows the co-authorship network connecting the top 25 collaborators of Kristina Ruuth. A scholar is included among the top collaborators of Kristina Ruuth based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kristina Ruuth. Kristina Ruuth is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Eynden, Jimmy Van den, Ganesh Umapathy, Kristina Ruuth, et al.. (2018). Phosphoproteome and gene expression profiling of ALK inhibition in neuroblastoma cell lines reveals conserved oncogenic pathways. Science Signaling. 11(557). 31 indexed citations
2.
Guan, Jikui, Yasuo Yamazaki, Damini Chand, et al.. (2017). Novel Mechanisms of ALK Activation Revealed by Analysis of the Y1278S Neuroblastoma Mutation. Cancers. 9(11). 149–149. 13 indexed citations
3.
Costa, Tiago R. D., et al.. (2016). YopN and TyeA Hydrophobic Contacts Required for Regulating Ysc-Yop Type III Secretion Activity by Yersinia pseudotuberculosis. Frontiers in Cellular and Infection Microbiology. 6. 66–66. 9 indexed citations
4.
Guan, Jikui, Elizabeth R. Tucker, Haisu Wan, et al.. (2016). The ALK inhibitor PF-06463922 is effective as a single agent in neuroblastoma driven by expression of ALK and MYCN. Disease Models & Mechanisms. 9(9). 941–952. 53 indexed citations
5.
Fransson, Susanne, Magnus Hansson, Kristina Ruuth, et al.. (2014). Intragenic anaplastic lymphoma kinase (ALK) rearrangements: Translocations as a novel mechanism of ALK activation in neuroblastoma tumors. Genes Chromosomes and Cancer. 54(2). 99–109. 34 indexed citations
6.
7.
Schönherr, Christina, Kristina Ruuth, Sattu Kamaraj, et al.. (2012). Anaplastic Lymphoma Kinase (ALK) regulates initiation of transcription of MYCN in neuroblastoma cells. Oncogene. 31(50). 5193–5200. 83 indexed citations
8.
Chand, Damini, Yasuo Yamazaki, Kristina Ruuth, et al.. (2012). Cell culture andDrosophilamodel systems define three classes of anaplastic lymphoma kinase mutations in neuroblastoma. Disease Models & Mechanisms. 6(2). 373–82. 45 indexed citations
9.
Schönherr, Christina, Kristina Ruuth, Therése Eriksson, et al.. (2011). The Neuroblastoma ALK(I1250T) Mutation Is a Kinase-Dead RTK In Vitro and In Vivo. Translational Oncology. 4(4). 258–IN6. 27 indexed citations
10.
Schönherr, Christina, Kristina Ruuth, Yasuo Yamazaki, et al.. (2011). Activating ALK mutations found in neuroblastoma are inhibited by Crizotinib and NVP-TAE684. Biochemical Journal. 440(3). 405–414. 60 indexed citations
11.
Blomberg, Jeanette, Andreas Höglund, David Eriksson, et al.. (2011). Inhibition of cellular FLICE-like inhibitory protein abolishes insensitivity to interferon-α and death receptor stimulation in resistant variants of the human U937 cell line. APOPTOSIS. 16(8). 783–794. 2 indexed citations
12.
Martinsson, Tommy, Therése Eriksson, Jonas Abrahamsson, et al.. (2010). Appearance of the Novel Activating F1174S ALK Mutation in Neuroblastoma Correlates with Aggressive Tumor Progression and Unresponsiveness to Therapy. Cancer Research. 71(1). 98–105. 59 indexed citations
13.
Sundström, Peter, Maria Nyström, Kristina Ruuth, & Erik Lundgren. (2009). Antibodies to specific EBNA-1 domains and HLA DRB1⁎1501 interact as risk factors for multiple sclerosis. Journal of Neuroimmunology. 215(1-2). 102–107. 81 indexed citations
14.
Blomberg, Jeanette, et al.. (2008). Reduced FAS transcription in clones of U937 cells that have acquired resistance to Fas‐induced apoptosis. FEBS Journal. 276(2). 497–508. 5 indexed citations
15.
Nyström, Maria, Kristina Ruuth, Erik Lundgren, & Peter Sundström. (2007). No support for a truncated interferon‐α17 allele as risk factor for MS. European Journal of Neurology. 14(11). 1302–1304. 2 indexed citations
16.
Ruuth, Kristina, et al.. (2007). Differential resistance of melanoma cells to treatment with recombinant IFN-alpha2b and leukocyte IFN.. PubMed. 27(4B). 2109–14. 3 indexed citations
17.
Ruuth, Kristina, Lennart Carlsson, Bengt Hallberg, & Erik Lundgren. (2001). Interferon-α Promotes Survival of Human Primary B-Lymphocytes via Phosphatidylinositol 3-Kinase. Biochemical and Biophysical Research Communications. 284(3). 583–586. 61 indexed citations
18.
Kandefer‐Szerszeń, Martyna, Kristina Ruuth, & Erik Lundgren. (1997). Effect of suramin on human interferon alpha binding to cell receptors.. PubMed. 45(1). 93–9. 3 indexed citations
19.
Ruuth, Kristina, et al.. (1995). The cytoplasmic C-terminal domain but not the N-terminal domain of latent membrane protein 1 of Epstein--Barr virus is essential for B cell activation. Journal of General Virology. 76(4). 767–777. 3 indexed citations
20.
Malmqvist, Magnus, J. Carlsson, Lennart Johansson, et al.. (1987). Characterization of monoclonal anti-DNA antibodies and visualization of binding to chromosomes and cell nuclei. Journal of Immunological Methods. 103(1). 109–119. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rama Jasty Breakdown of academic impact, for papers by David Eaves Breakdown of academic impact, for papers by John M. Krill-Burger Breakdown of academic impact, for papers by Jacqueline A. Brosnan‐Cashman Breakdown of academic impact, for papers by Teresa Corral Breakdown of academic impact, for papers by Curt J. Essenburg Breakdown of academic impact, for papers by Torill Høiby Breakdown of academic impact, for papers by Octavio A. Romero Breakdown of academic impact, for papers by T Sugimura Breakdown of academic impact, for papers by Neetha Parameswaran
Rankless by CCL
2026